Cabozantinib hydrochloride

CAS No. ——

Cabozantinib hydrochloride ( XL184 | BMS-907351 )

Catalog No. M19952 CAS No. ——

Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 Get Quote
5MG 70 Get Quote
10MG 108 Get Quote
25MG 188 Get Quote
50MG 283 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cabozantinib hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).
  • Description
    Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    XL184 | BMS-907351
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    c-Kit| c-Met| VEGFR2/KDR| FLT4| Axl|RORγ|RORα
  • Research Area
    Cancer
  • Indication
    Adrenocortical carcinoma; Bone metastases; Brain metastases; Breast Cancer; Cholangiocarcinoma; Endometrial Cancer; Ewing's sarcoma

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    537.96
  • Molecular Formula
    C28H25ClFN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 80 mg/mL
  • SMILES
    Cl.COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yakes FM et al. Cabozantinib (XL184) a novel MET and VEGFR2 inhibitor simultaneously suppresses metastasis angiogenesis and tumor growth. Mol Cancer Ther 2011 10(12) 2298-2308.
molnova catalog
related products
  • MGCD-265

    MGCD-265 is a potent, multi-target and ATP-competitive inhibitor of c-Met and VEGFR1/2/3 with IC50 of 1 nM, 3 nM/3 nM/4 nM, respectively.

  • TRX818

    TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.

  • Dihexa

    Dihexa is an activator of the hepatocyte growth factor/c-Met (HGF/c-Met) systemit binds to HGF (Kd = 65 pM)and an analog of the peptide angiotensin IV.